Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

被引:0
|
作者
Min Jeong Wang
SangHak Yi
Jee-young Han
So Young Park
Jae-Won Jang
In Kook Chun
Sang Eun Kim
Byoung Sub Lee
Gwang Je Kim
Ji Sun Yu
Kuntaek Lim
Sung Min Kang
Young Ho Park
Young Chul Youn
Seong Soo A. An
SangYun Kim
机构
[1] Seoul National University Bundang Hospital and Seoul National University College of Medicine,Department of Neurology
[2] Kangwon National University Hospital,Department of Neurology
[3] Kangwon National University Hospital and School of Medicine,Department of Nuclear Medicine
[4] Kangwon National University,Department of Nuclear Medicine
[5] Seoul National University Bundang Hospital and Seoul National University College of Medicine,Department of Research and Development
[6] PeopleBio,Department of Neurology
[7] Inc,Department of Bionano Technology, Gachon Medical Research Institute
[8] Chung-Ang University Hospital,undefined
[9] Gachon University,undefined
来源
Alzheimer's Research & Therapy | / 9卷
关键词
Amyloid-β protein; Oligomer; Alzheimer’s disease; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β
    Castellani, Rudy J.
    Lee, Hyoung-gon
    Siedlak, Sandra L.
    Nunomura, Akihiko
    Hayashi, Takaaki
    Nakamura, Masao
    Zhu, Xiongwei
    Perry, George
    Smith, Mark A.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 447 - 452
  • [32] Distinct localization of oligomeric amyloid β-protein as the therapeutic target for Alzheimer's disease
    Mori, Hiroshi
    Tomiyama, Takami
    NEUROBIOLOGY OF AGING, 2008, 29 : S18 - S19
  • [33] Cellular prion protein and Alzheimer disease Link to oligomeric amyloid-β and neuronal cell death
    Kudo, Wataru
    Petersen, Robert B.
    Lee, Hyoung-gon
    PRION, 2013, 7 (02) : 114 - 116
  • [34] Blood-based diagnostics of Alzheimer's disease
    Penner, Gregory
    Lecocq, Soizic
    Chopin, Anaelle
    Vedoya, Ximena
    Lista, Simone
    Vergallo, Andrea
    Lejeune, Francois-Xavier
    Hampel, Harald
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (07) : 613 - 621
  • [35] Model of Alzheimer's disease amyloid-β peptide based on a RNA binding protein
    Mathura, VS
    Paris, D
    Ait-Ghezala, G
    Quadros, A
    Patel, NS
    Kolippakkam, DN
    Volmar, CH
    Mullan, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (02) : 585 - 592
  • [36] Plasma Levels of Amyloid-β Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease
    Castillo-Mendieta, Tzayaka
    Arana-Lechuga, Yoaly
    Campos-Pena, Victoria
    Luisa Sosa, Ana
    Orozco-Suarez, Sandra
    Pinto-Almazan, Rodolfo
    Segura-Uribe, Julia
    Rodriguez-Sanchez de Tagle, Aldo Javier
    Ruiz-Sanchez, Elizabeth
    Guerra-Araiza, Christian
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 : S271 - S281
  • [37] Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease
    Jonathan Vogelgsang
    Hedieh Shahpasand-Kroner
    Rebekka Vogelgsang
    Frank Streit
    Ruth Vukovich
    Jens Wiltfang
    Experimental Brain Research, 2018, 236 : 1241 - 1250
  • [38] Plasma Insulin Predicts Early Amyloid-β Pathology Changes in Alzheimer's Disease
    Chen, Yu-Han
    Wang, Zhi-Bo
    Liu, Xi-Peng
    Mao, Zhi-Qi
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 (01) : 321 - 332
  • [39] Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer's Disease
    Kim, Dong Eun
    Priefer, Ronny
    BRAIN SCIENCES, 2020, 10 (02)
  • [40] Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
    Young Chul Youn
    Sungmin Kang
    Jeewon Suh
    Young Ho Park
    Min Ju Kang
    Jung-Min Pyun
    Seong Hye Choi
    Jee Hyang Jeong
    Kyung Won Park
    Ho-Won Lee
    Seong Soo A. An
    Jacqueline C. Dominguez
    SangYun Kim
    Alzheimer's Research & Therapy, 11